5 nov 2019
CPhI Worldwide 2019
PT FERRON PAR PHARMACEUTICALS

PT FERRON PAR PHARMACEUTICALS

Exhibitor at CPhI Worldwide 2019 stand 92A30, Finished Dosage Formulations

About us

Dexa Group, is a Global Company and Top 3 Indonesia’s biggest companies and one of the top generic pharmaceutical company in South East Asia, with multiple manufacturing sites across the country. We are present in four continents (America, Europe, Asia and Africa) and looking for reliable partner for some activity with cooperation schemes : CMO, CRO, co-development, out-licensing, in-licensing, and export products.

Ferron Par Pharmaceuticals is a member of Dexa Group. The GMP standard of the facility is preserved at exceptional standard level. It is approved by MHRA UK, and Germany authority. And further, ISO 9001 is also granted. do export regularly our products to UK, Polish and Netherland market and some other countries such as Singapore, Philippines, Vietnam, Cambodia, Singapore, Malaysia, etc. Ferron itself was established in 2002, with the capability to manufacture Finished Dosage Form, injectable products, semisolid dosage form, and oral liquid dosage form. Recently, we also complete our sterile line by producing sterilized bulk API and sterile oncology products.







Specs about this supplier

Affiliated categories: Contract Manufacturing |Generic APIs |Finished Dosage Forms More

Products featured at CPhI Worldwide 2019

PT FERRON PAR PHARMACEUTICALS

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 92A30